Trupanion, Inc. (NASDAQ:TRUP) Sees Large Increase in Short Interest

Key Points

• Trupanion, Inc. (NASDAQ:TRUP) saw a staggering 29,780.0% increase in short interest, reaching a total of 7,470,000 shares as of July 15th.
• Recent insider transactions revealed that COO John R. Gallagher and CFO Fawwad Qureshi sold a combined total of 11,562 shares, reflecting a notable decrease in their holdings.
• Analysts have set a consensus price target of $53.80 for Trupanion, with recommendations ranging from "hold" to "strong buy" based on recent performance reports.

Trupanion, Inc. (NASDAQ:TRUP - Get Free Report) saw a significant increase in short interest in July. As of July 15th, there was short interest totaling 7,470,000 shares, anincreaseof29,780.0% from the June 30th total of 25,000 shares. Approximately24.7% of the company's shares are short sold. Based on an average trading volume of 556,600 shares, the short-interest ratio is currently 13.4 days. Based on an average trading volume of 556,600 shares, the short-interest ratio is currently 13.4 days. Approximately24.7% of the company's shares are short sold.

Trupanion Price Performance

Shares of TRUP traded up $1.27 during mid-day trading on Tuesday, hitting $48.57. 180,971 shares of the company were exchanged, compared to its average volume of 597,021. Trupanion has a 1-year low of $31.00 and a 1-year high of $57.90. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.70 and a current ratio of 1.70. The company has a 50 day moving average of $51.05 and a 200-day moving average of $43.95. The stock has a market cap of $2.08 billion, a price-to-earnings ratio of -486.09 and a beta of 1.78.

Insider Buying and Selling

In related news, CEO Margaret Tooth sold 4,000 shares of Trupanion stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $45.86, for a total value of $183,440.00. Following the completion of the transaction, the chief executive officer owned 118,784 shares in the company, valued at approximately $5,447,434.24. This trade represents a 3.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, COO John R. Gallagher sold 4,000 shares of the business's stock in a transaction that occurred on Thursday, May 29th. The shares were sold at an average price of $47.90, for a total value of $191,600.00. Following the transaction, the chief operating officer owned 26,966 shares of the company's stock, valued at $1,291,671.40. This trade represents a 12.92% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 11,562 shares of company stock worth $544,870. Corporate insiders own 5.42% of the company's stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Raymond James Financial Inc. purchased a new position in shares of Trupanion during the 4th quarter worth approximately $593,000. Commonwealth Equity Services LLC lifted its position in shares of Trupanion by 13.4% during the 4th quarter. Commonwealth Equity Services LLC now owns 16,345 shares of the financial services provider's stock worth $788,000 after purchasing an additional 1,928 shares during the last quarter. American Century Companies Inc. purchased a new stake in shares of Trupanion during the 4th quarter worth $1,111,000. Sei Investments Co. raised its stake in Trupanion by 36.1% during the 4th quarter. Sei Investments Co. now owns 6,818 shares of the financial services provider's stock worth $329,000 after acquiring an additional 1,810 shares in the last quarter. Finally, KLP Kapitalforvaltning AS acquired a new stake in Trupanion during the 4th quarter worth $304,000.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Piper Sandler raised their target price on Trupanion from $52.00 to $62.00 and gave the stock an "overweight" rating in a research note on Thursday, July 3rd. Lake Street Capital lowered their target price on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a research note on Friday, May 2nd. Two equities research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $53.80.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.